Literature DB >> 3776976

Peak expiratory flow and risk of cardiovascular disease and death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden.

C Persson, C Bengtsson, L Lapidus, E Rybo, G Thiringer, H Wedel.   

Abstract

A longitudinal population study of 1,462 women, aged 38-60 years at entry, was begun in Gothenburg, Sweden, in 1968-1969. This paper deals with the first 12-year follow-up period. In univariate analysis, peak expiratory flow showed a significant negative correlation with the 12-year incidences of myocardial infarction, electrocardiographic changes suggesting ischemic heart disease, stroke, and death. The association with incidence of myocardial infarction, stroke, and death remained in multivariate analysis, and was independent of age, body height, body mass index, adipose tissue distribution, chest deformity, history of pulmonary disease, smoking habit, serum cholesterol concentration, serum triglyceride concentration, systolic blood pressure, diabetes, and physical activity. The findings indicate that measuring peak expiratory flow is a simple procedure to identify women with an increased risk of cardiovascular disease or death. It seems urgent to find out what preventive measures might be taken as a consequence of these observations.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3776976     DOI: 10.1093/oxfordjournals.aje.a114483

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  24 in total

1.  Ventilatory function, height, and mortality among lifelong non-smokers.

Authors:  D P Strachan
Journal:  J Epidemiol Community Health       Date:  1992-02       Impact factor: 3.710

2.  Ventilatory function as a predictor of fatal stroke.

Authors:  D P Strachan
Journal:  BMJ       Date:  1991-01-12

3.  Adherence to Oral Medications for Hypertension and Diabetes in Veterans with Comorbid Airflow Limitation.

Authors:  Anne C Melzer; Jane Uman; David H Au
Journal:  Ann Am Thorac Soc       Date:  2015-06

4.  Combined effect of lung function level and decline increases morbidity and mortality risks.

Authors:  Penelope Baughman; Jacob L Marott; Peter Lange; Christopher J Martin; Anoop Shankar; Edward L Petsonk; Eva Hnizdo
Journal:  Eur J Epidemiol       Date:  2012-12-14       Impact factor: 8.082

5.  Risk factors for death from asthma, chronic obstructive pulmonary disease, and cardiovascular disease after a hospital admission for asthma.

Authors:  H F Guite; R Dundas; P G Burney
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

6.  Height and mortality after myocardial infarction.

Authors:  C R Rosenberg; R E Shore; B S Pasternack
Journal:  J Community Health       Date:  1995-08

7.  Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study.

Authors:  D J Hole; G C Watt; G Davey-Smith; C L Hart; C R Gillis; V M Hawthorne
Journal:  BMJ       Date:  1996-09-21

8.  Arterial inflammation in bronchial asthma.

Authors:  Jayanthi Vijayakumar; Sharath Subramanian; Parmanand Singh; Erin Corsini; Sara Fontanez; Meredith Lawler; Rebecca Kaplan; Thomas J Brady; Udo Hoffmann; Ahmed Tawakol
Journal:  J Nucl Cardiol       Date:  2013-03-23       Impact factor: 5.952

9.  Regional differences in prediction models of lung function in Germany.

Authors:  Eva Schnabel; Chih-Mei Chen; Beate Koch; Stefan Karrasch; Rudolf A Jörres; Torsten Schäfer; Claus Vogelmeier; Ralf Ewert; Christoph Schäper; Henry Völzke; Anne Obst; Stephan B Felix; H-Erich Wichmann; Sven Gläser; Joachim Heinrich
Journal:  Respir Res       Date:  2010-04-22

10.  The importance of lung function, non-malignant diseases associated with asbestos, and symptoms as predictors of ischaemic heart disease in shipyard workers exposed to asbestos.

Authors:  A Sandén; B Järvholm; S Larsson
Journal:  Br J Ind Med       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.